RH-125

N/A

Report date: 2026/05/12 09:17:12

Base Information

Drug NameRH-125
Drug Alias NamePersonalized mRNA Tumor Vaccine (Cancer Hospital Chinese Academy Of Medical Sciences, Shenzhen Center)RH125RH-125
ClassificationVaccines > Application > Therapeutic vaccineVaccines > Development/production technology > Nucleic acid vaccine > RNA vaccine > mRNA vaccine > personalized mRNA cancer vaccines
Mechanisms of ActionImmunostimulants
TargetsNot applicable
Therapy Area/IndicationsSolid tumours
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaPhase 1 Clinical
Originator CompaniesCancer Hospital Chinese Academy Of Medical Sciences, Shenzhen Center
China Registration ClassN/A

Develop Information

Active CompaniesCancer Hospital Chinese Academy Of Medical Sciences, Shenzhen Center
Inactive CompaniesN/A
Active IndicationsSolid tumours
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A